valproic acid has been researched along with Hemorrhagic Shock in 49 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Excerpt | Relevance | Reference |
---|---|---|
" Valproic acid (VPA) alleviates hemorrhagic shock (HS)-induced ALI (HS/ALI) and inhibits TF expression in monocytes." | 8.31 | VALPROIC ACID INHIBITS CLASSICAL MONOCYTE-DERIVED TISSUE FACTOR AND ALLEVIATES HEMORRHAGIC SHOCK-INDUCED ACUTE LUNG INJURY IN RATS. ( Chong, W; Liu, C; Shao, L; Wu, B, 2023) |
"Histone deacetylase inhibitors such as valproic acid (VPA) improve survival in lethal models of hemorrhagic shock and polytrauma." | 7.88 | Rapid valproic acid-induced modulation of the traumatic proteome in a porcine model of traumatic brain injury and hemorrhagic shock. ( Alam, HB; Dennahy, IS; Georgoff, PE; Ghandour, MH; Higgins, GA; Nikolian, VC; Remmer, H; Weykamp, M, 2018) |
"We have previously shown that resuscitation with fresh frozen plasma (FFP) in a large animal model of traumatic brain injury (TBI) and hemorrhagic shock (HS) decreases the size of the brain lesion, and that addition of a histone deacetylase inhibitor, valproic acid (VPA), provides synergistic benefits." | 7.80 | Treatment with a histone deacetylase inhibitor, valproic acid, is associated with increased platelet activation in a large animal model of traumatic brain injury and hemorrhagic shock. ( Alam, HB; Andjelkovic, AV; Bambakidis, T; Boer, C; Dekker, SE; Halaweish, I; Jin, G; Johansson, PI; Linzel, D; Liu, B; Sillesen, M, 2014) |
"Valproic acid (VPA) has been shown to improve survival in animal models of hemorrhagic shock at a dose of 300 mg/kg." | 7.80 | Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study. ( Alam, HB; Halaweish, I; Hwabejire, JO; Li, Y; Liu, B; Lu, J, 2014) |
"We have demonstrated that valproic acid (VPA), a histone deacetylase inhibitor, can improve animal survival after hemorrhagic shock and protect neurons from hypoxia-induced apoptosis." | 7.74 | Cell protective mechanism of valproic acid in lethal hemorrhagic shock. ( Alam, HB; Butt, MU; deMoya, M; Li, Y; Liu, B; Sailhamer, EA; Shuja, F; Shults, C; Velmahos, GC; Yuan, Z, 2008) |
"Valproic acid-treated animals had significantly less neurologic impairment on days 2 (16." | 7.30 | Prolonging the therapeutic window for valproic acid treatment in a swine model of traumatic brain injury and hemorrhagic shock. ( Alam, HB; Chtraklin, K; Dimonte, D; Ho, JW; Jin, G; Joaquin, TA; Keeney-Bonthrone, TP; Latif, Z; Ober, RA; Pai, MP; Vercruysse, C; Wen, B, 2023) |
"Valproic acid (VPA) has been extensively used for treatment of anxiety and seizure." | 5.72 | Valproic acid during hypotensive resuscitation in pigs with trauma and hemorrhagic shock does not improve survival. ( Bynum, J; Cap, AP; Martini, WZ; Ryan, KL; Xia, H, 2022) |
"Valproic acid-treated animals demonstrated significantly less neurologic impairment on PID 1 and returned to baseline faster (PID 1 mean neurologic severity score, control = 22 ± 3 vs." | 5.62 | Administration of valproic acid in clinically approved dose improves neurologic recovery and decreases brain lesion size in swine subjected to hemorrhagic shock and traumatic brain injury. ( Alam, HB; Bhatti, UF; Biesterveld, BE; Chtraklin, K; Kemp, MT; O'Connell, RL; Pai, MP; Siddiqui, AZ; Srinivasan, A; Vercruysse, CA; Wakam, GK; Williams, AM, 2021) |
"Combined traumatic brain injury and hemorrhagic shock are highly lethal." | 5.48 | Improvement of Blood-Brain Barrier Integrity in Traumatic Brain Injury and Hemorrhagic Shock Following Treatment With Valproic Acid and Fresh Frozen Plasma. ( Alam, HB; Andjelkovic, AV; Bambakidis, T; Dekker, SE; Dennahy, IS; Georgoff, PE; Higgins, GA; Nikolian, VC; Williams, AM, 2018) |
"Valproic acid (VPA) is a histone deacetylase inhibitor that improves outcomes in large animal models of trauma." | 5.48 | Valproic acid induces prosurvival transcriptomic changes in swine subjected to traumatic injury and hemorrhagic shock. ( Alam, HB; Athey, B; Chtraklin, K; Eidy, H; Georgoff, PE; Ghandour, MH; Higgins, G; Nikolian, VC; Williams, A, 2018) |
"Valproic acid-treated animals demonstrated significantly less neurologic impairment between PID 1 to 5 and smaller brain lesions on PID 3 (mean lesion size ± SEM, mm: ISCS = 4,956 ± 1,511 versus ISCS + VPA = 828 ± 279; p = 0." | 5.46 | Valproic acid decreases brain lesion size and improves neurologic recovery in swine subjected to traumatic brain injury, hemorrhagic shock, and polytrauma. ( Alam, HB; Chtraklin, K; Dennahy, IS; Eidy, H; Georgoff, PE; Ghandour, MH; Han, Y; Li, Y; Nikolian, VC; Pai, MP; Srinivasan, A, 2017) |
"Traumatic brain injury and hemorrhagic shock (TBI+HS) elicit a complex inflammatory response that contributes to secondary brain injury." | 5.43 | Resuscitation with Valproic Acid Alters Inflammatory Genes in a Porcine Model of Combined Traumatic Brain Injury and Hemorrhagic Shock. ( Alam, HB; Bambakidis, T; de Vries, HE; Dekker, SE; Jin, G; Johnson, CN; Li, Y; Liu, B; Sillesen, M, 2016) |
"Traumatic brain injury (TBI) and hemorrhagic shock (HS) are major causes of trauma-related deaths and are especially lethal as a combined insult." | 5.39 | Synergistic effects of fresh frozen plasma and valproic acid treatment in a combined model of traumatic brain injury and hemorrhagic shock. ( Alam, HB; deMoya, MA; DePeralta, D; Duggan, M; Hwabejire, JO; Imam, AM; Jepsen, CH; Jin, G; Liu, B; Lu, J; Sillesen, M; Socrate, S, 2013) |
"Wistar-Kyoto rats underwent hemorrhagic shock (60% blood loss) followed by treatment with or without VPA (300 mg/kg)." | 5.36 | Identification of a novel potential biomarker in a model of hemorrhagic shock and valproic acid treatment. ( Alam, HB; deMoya, M; Dillon, ST; Fukudome, EY; Kheirbek, T; Li, Y; Libermann, TA; Liu, B; Sailhamer, EA; Velmahos, G, 2010) |
" Valproic acid (VPA) alleviates hemorrhagic shock (HS)-induced ALI (HS/ALI) and inhibits TF expression in monocytes." | 4.31 | VALPROIC ACID INHIBITS CLASSICAL MONOCYTE-DERIVED TISSUE FACTOR AND ALLEVIATES HEMORRHAGIC SHOCK-INDUCED ACUTE LUNG INJURY IN RATS. ( Chong, W; Liu, C; Shao, L; Wu, B, 2023) |
"We previously showed that the addition of valproic acid (VPA), a histone deacetylase inhibitor, to fresh frozen plasma (FFP) resuscitation attenuates brain lesion size and swelling following traumatic brain injury (TBI) and hemorrhagic shock (HS)." | 4.02 | Modulation of Brain Transcriptome by Combined Histone Deacetylase Inhibition and Plasma Treatment Following Traumatic Brain Injury and Hemorrhagic Shock. ( Alam, HB; Bambakidis, T; Biesterveld, BE; Dekker, SE; Johnson, CN; Li, Y; Liu, B; Sillesen, M; Tagett, R; Williams, AM, 2021) |
" The histone deacetylase inhibitor, high-dose valproic acid (VPA) has been shown to have cytoprotective potential in models of combined TBI and hemorrhagic shock, but it has not been tested in an isolated TBI model." | 3.96 | Valproic acid treatment rescues injured tissues after traumatic brain injury. ( Alam, HB; Biesterveld, BE; Iancu, A; Kemp, MT; O'Connell, RL; Pai, MP; Pumiglia, L; Remmer, HA; Shamshad, AA; Siddiqui, AZ; Wakam, GK; Williams, AM, 2020) |
" Nonselective histone deacetylase inhibitors (HDACIs), such as valproic acid (VPA), have been shown to improve outcomes in hemorrhagic shock (HS)." | 3.88 | Histone deacetylase inhibitors: Isoform selectivity improves survival in a hemorrhagic shock model. ( Alam, HB; Bhatti, UF; Chang, P; Dennahy, IS; Li, Y; Liu, B; Nikolian, VC; Weykamp, M; Williams, AM, 2018) |
"Histone deacetylase inhibitors such as valproic acid (VPA) improve survival in lethal models of hemorrhagic shock and polytrauma." | 3.88 | Rapid valproic acid-induced modulation of the traumatic proteome in a porcine model of traumatic brain injury and hemorrhagic shock. ( Alam, HB; Dennahy, IS; Georgoff, PE; Ghandour, MH; Higgins, GA; Nikolian, VC; Remmer, H; Weykamp, M, 2018) |
"To determine the mechanism of action of valproic acid (VPA) in the adult central nervous system (CNS) following traumatic brain injury (TBI) and hemorrhagic shock (HS)." | 3.85 | Network Reconstruction Reveals that Valproic Acid Activates Neurogenic Transcriptional Programs in Adult Brain Following Traumatic Injury. ( Alam, HE; Allyn-Feuer, A; Athey, BD; Georgoff, P; Higgins, GA; Higgins, R; Nikolian, V; Pauls, B, 2017) |
"Therapeutic hypothermia (hypo) and valproic acid (VPA, a histone deacetylase inhibitor) have independently been shown to be protective in models of trauma and hemorrhagic shock but require logistically challenging doses to be effective." | 3.81 | Hypothermia and valproic acid activate prosurvival pathways after hemorrhage. ( Alam, HB; Bambakidis, T; Chtraklin, K; Dekker, SE; Li, Y; Linzel, D; Liu, B; Maxwell, J, 2015) |
"To investigate the consequences of histone deacetylase inhibition by histone deacetylase inhibitor valproic acid and IκB kinase/nuclear factor-κB signaling blockade by IκB kinase inhibitor BAY11-7082 on (microvascular) endothelial cell behavior in vitro as well as in mice subjected to hemorrhagic shock/resuscitation in vivo." | 3.81 | Histone Deacetylase Inhibition and IκB Kinase/Nuclear Factor-κB Blockade Ameliorate Microvascular Proinflammatory Responses Associated With Hemorrhagic Shock/Resuscitation in Mice. ( Aslan, A; Jongman, RM; Li, R; Molema, G; Moorlag, HE; Moser, J; van Meurs, M; Yan, R; Zijlstra, JG; Zwiers, PJ, 2015) |
"We have previously shown that addition of valproic acid (VPA; a histone deacetylase inhibitor) to hetastarch (Hextend [HEX]) resuscitation significantly decreases lesion size in a swine model of traumatic brain injury (TBI) and hemorrhagic shock (HS)." | 3.80 | Effect of pharmacologic resuscitation on the brain gene expression profiles in a swine model of traumatic brain injury and hemorrhage. ( Alam, HB; Bambakidis, T; Dekker, SE; Jin, G; Johnson, CN; Li, Y; Liu, B; Sillesen, M, 2014) |
"We have previously shown that resuscitation with fresh frozen plasma (FFP) in a large animal model of traumatic brain injury (TBI) and hemorrhagic shock (HS) decreases the size of the brain lesion, and that addition of a histone deacetylase inhibitor, valproic acid (VPA), provides synergistic benefits." | 3.80 | Treatment with a histone deacetylase inhibitor, valproic acid, is associated with increased platelet activation in a large animal model of traumatic brain injury and hemorrhagic shock. ( Alam, HB; Andjelkovic, AV; Bambakidis, T; Boer, C; Dekker, SE; Halaweish, I; Jin, G; Johansson, PI; Linzel, D; Liu, B; Sillesen, M, 2014) |
"We have previously demonstrated that valproic acid (VPA), a histone deacetylase inhibitor, can improve survival after hemorrhagic shock (HS), protect neurons from hypoxia-induced apoptosis, and attenuate the inflammatory response." | 3.78 | Pharmacologic resuscitation for hemorrhagic shock combined with traumatic brain injury. ( Alam, HB; Demoya, MA; Duggan, M; Hwabejire, J; Imam, A; Jepsen, CH; Jin, G; Liu, B; Lu, J; Mejaddam, AY; Sillesen, M; Smith, WM; Socrate, S; Velmahos, GC, 2012) |
"We have demonstrated previously that valproic acid (VPA), a histone deacetylase inhibitor, can improve survival in lethal models of hemorrhagic shock." | 3.75 | Surviving blood loss without blood transfusion in a swine poly-trauma model. ( Alam, HB; Butt, MU; Demoya, M; Duggan, M; Fukudome, EY; Li, Y; Liu, B; Shuja, F; Velmahos, GC; Zacharias, N, 2009) |
"We have demonstrated that valproic acid (VPA), a histone deacetylase inhibitor (HDACI), can improve animal survival after hemorrhagic shock, and protect neurons from hypoxia-induced apoptosis." | 3.75 | Pharmacologic resuscitation: cell protective mechanisms of histone deacetylase inhibition in lethal hemorrhagic shock. ( Alam, HB; Butt, MU; DeMoya, M; King, DR; Li, Y; Liu, B; Sailhamer, EA; Shuja, F; Velmahos, GC, 2009) |
"Valproic acid-treated animals had significantly less neurologic impairment on days 2 (16." | 3.30 | Prolonging the therapeutic window for valproic acid treatment in a swine model of traumatic brain injury and hemorrhagic shock. ( Alam, HB; Chtraklin, K; Dimonte, D; Ho, JW; Jin, G; Joaquin, TA; Keeney-Bonthrone, TP; Latif, Z; Ober, RA; Pai, MP; Vercruysse, C; Wen, B, 2023) |
"Valproic acid (VPA) has been extensively used for treatment of anxiety and seizure." | 1.72 | Valproic acid during hypotensive resuscitation in pigs with trauma and hemorrhagic shock does not improve survival. ( Bynum, J; Cap, AP; Martini, WZ; Ryan, KL; Xia, H, 2022) |
"Valproic acid-treated animals demonstrated significantly less neurologic impairment on PID 1 and returned to baseline faster (PID 1 mean neurologic severity score, control = 22 ± 3 vs." | 1.62 | Administration of valproic acid in clinically approved dose improves neurologic recovery and decreases brain lesion size in swine subjected to hemorrhagic shock and traumatic brain injury. ( Alam, HB; Bhatti, UF; Biesterveld, BE; Chtraklin, K; Kemp, MT; O'Connell, RL; Pai, MP; Siddiqui, AZ; Srinivasan, A; Vercruysse, CA; Wakam, GK; Williams, AM, 2021) |
"Valproic acid (VPA) has been shown to attenuate brain lesion size and swelling within the first few hours following TBI." | 1.62 | Pharmacologic modulation of brain metabolism by valproic acid can induce a neuroprotective environment. ( Alam, HB; Bhatti, UF; Biesterveld, BE; Dennahy, IS; Kachman, M; Karnovsky, A; Li, Y; Liu, B; Nikolian, VC; O'Connell, RL; Siddiqui, A; Williams, AM, 2021) |
"Valproic acid (VPA) has been shown to have beneficial properties in lethal hemorrhage/trauma models." | 1.51 | Valproic acid improves survival and decreases resuscitation requirements in a swine model of prolonged damage control resuscitation. ( Alam, HB; Bhatti, UF; Biesterveld, BE; Chtraklin, K; Dennahy, IS; Graham, NJ; Kathawate, RG; Li, Y; Russo, RM; Vercruysse, CA; Williams, AM; Zhou, J, 2019) |
"Valproic acid (VPA) is a histone deacetylase inhibitor that improves outcomes in large animal models of trauma." | 1.48 | Valproic acid induces prosurvival transcriptomic changes in swine subjected to traumatic injury and hemorrhagic shock. ( Alam, HB; Athey, B; Chtraklin, K; Eidy, H; Georgoff, PE; Ghandour, MH; Higgins, G; Nikolian, VC; Williams, A, 2018) |
"Combined traumatic brain injury and hemorrhagic shock are highly lethal." | 1.48 | Improvement of Blood-Brain Barrier Integrity in Traumatic Brain Injury and Hemorrhagic Shock Following Treatment With Valproic Acid and Fresh Frozen Plasma. ( Alam, HB; Andjelkovic, AV; Bambakidis, T; Dekker, SE; Dennahy, IS; Georgoff, PE; Higgins, GA; Nikolian, VC; Williams, AM, 2018) |
"Valproic acid-treated animals demonstrated significantly less neurologic impairment between PID 1 to 5 and smaller brain lesions on PID 3 (mean lesion size ± SEM, mm: ISCS = 4,956 ± 1,511 versus ISCS + VPA = 828 ± 279; p = 0." | 1.46 | Valproic acid decreases brain lesion size and improves neurologic recovery in swine subjected to traumatic brain injury, hemorrhagic shock, and polytrauma. ( Alam, HB; Chtraklin, K; Dennahy, IS; Eidy, H; Georgoff, PE; Ghandour, MH; Han, Y; Li, Y; Nikolian, VC; Pai, MP; Srinivasan, A, 2017) |
"Valproic acid (VPA) has been associated with improved outcomes in multiple models of trauma, when combined with isotonic fluid resuscitation." | 1.46 | Lung Protective Effects of Low-Volume Resuscitation and Pharmacologic Treatment of Swine Subjected to Polytrauma and Hemorrhagic Shock. ( Alam, HB; Dennahy, IS; Duan, X; Duggan, MJ; Georgoff, PE; Li, Y; Liu, B; Mesar, T; Nikolian, VC; Pan, B; Wu, X, 2017) |
"Traumatic brain injury and hemorrhagic shock (TBI+HS) elicit a complex inflammatory response that contributes to secondary brain injury." | 1.43 | Resuscitation with Valproic Acid Alters Inflammatory Genes in a Porcine Model of Combined Traumatic Brain Injury and Hemorrhagic Shock. ( Alam, HB; Bambakidis, T; de Vries, HE; Dekker, SE; Jin, G; Johnson, CN; Li, Y; Liu, B; Sillesen, M, 2016) |
"Traumatic brain injury (TBI) and hemorrhagic shock (HS) are major causes of trauma-related deaths and are especially lethal as a combined insult." | 1.39 | Synergistic effects of fresh frozen plasma and valproic acid treatment in a combined model of traumatic brain injury and hemorrhagic shock. ( Alam, HB; deMoya, MA; DePeralta, D; Duggan, M; Hwabejire, JO; Imam, AM; Jepsen, CH; Jin, G; Liu, B; Lu, J; Sillesen, M; Socrate, S, 2013) |
"In a clinically relevant lethal polytrauma model, administration of SDP significantly improves survival without any long-term organ dysfunction or complications." | 1.37 | Hemostatic and pharmacologic resuscitation: results of a long-term survival study in a swine polytrauma model. ( Alam, HB; Bramos, A; Chong, W; Duggan, M; Fikry, K; Fukudome, EY; Hamwi, KB; Kim, K; Lu, J; Velmahos, G, 2011) |
"Here a case of hemorrhagic shock and fulminant hepatic failure in a patient treated with valproate is presented." | 1.29 | [Hemorrhagic shock and fulminant hepatic failure associated with valproate]. ( Fernandez-Fernandez, FJ; Garcia-Jimenez, A; Garcia-Rego, J; Sesma, P, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.04) | 18.2507 |
2000's | 6 (12.24) | 29.6817 |
2010's | 33 (67.35) | 24.3611 |
2020's | 9 (18.37) | 2.80 |
Authors | Studies |
---|---|
Martini, WZ | 1 |
Xia, H | 1 |
Ryan, KL | 1 |
Bynum, J | 1 |
Cap, AP | 1 |
Shao, L | 3 |
Wu, B | 3 |
Liu, C | 3 |
Chong, W | 5 |
Jin, G | 7 |
Ho, JW | 1 |
Keeney-Bonthrone, TP | 1 |
Pai, MP | 5 |
Wen, B | 1 |
Ober, RA | 1 |
Dimonte, D | 1 |
Chtraklin, K | 9 |
Joaquin, TA | 1 |
Latif, Z | 1 |
Vercruysse, C | 1 |
Alam, HB | 38 |
Biesterveld, BE | 8 |
Williams, AM | 10 |
Dennahy, IS | 9 |
Graham, NJ | 2 |
Siddiqui, AZ | 4 |
OʼConnell, RL | 1 |
Bhatti, UF | 8 |
Liu, B | 25 |
Russo, RM | 2 |
Li, Y | 26 |
Russo, R | 1 |
Kemp, M | 1 |
Pai, M | 1 |
Wakam, G | 1 |
Biesterveld, B | 1 |
Kemp, MT | 3 |
Wakam, GK | 3 |
O'Connell, RL | 4 |
Shamshad, A | 1 |
Pumiglia, L | 1 |
Iancu, A | 1 |
Shamshad, AA | 1 |
Remmer, HA | 1 |
Dekker, SE | 8 |
Bambakidis, T | 9 |
Tagett, R | 1 |
Johnson, CN | 3 |
Sillesen, M | 10 |
Karnovsky, A | 1 |
Kachman, M | 1 |
Nikolian, VC | 10 |
Siddiqui, A | 1 |
Srinivasan, A | 3 |
Vercruysse, CA | 2 |
Pan, B | 1 |
Mesar, T | 1 |
Georgoff, PE | 6 |
Duan, X | 2 |
Wu, X | 1 |
Duggan, MJ | 1 |
Eidy, H | 2 |
Ghandour, MH | 3 |
Han, Y | 1 |
Schober, P | 1 |
Higgins, GA | 3 |
Andjelkovic, AV | 2 |
Higgins, G | 1 |
Williams, A | 1 |
Athey, B | 1 |
Chang, P | 2 |
Weykamp, M | 2 |
Remmer, H | 1 |
Lee, J | 1 |
Zhou, J | 1 |
Kathawate, RG | 1 |
Hwabejire, JO | 3 |
Imam, AM | 2 |
Duggan, M | 5 |
Deperalta, D | 2 |
Jepsen, CH | 3 |
Lu, J | 7 |
deMoya, MA | 4 |
Socrate, S | 2 |
Halaweish, I | 5 |
Liu, Z | 1 |
Deperalta, DK | 1 |
Zhou, P | 1 |
Boer, C | 1 |
Johansson, PI | 1 |
Linzel, D | 2 |
Maxwell, J | 1 |
Li, R | 1 |
Aslan, A | 1 |
Yan, R | 1 |
Jongman, RM | 1 |
Moser, J | 1 |
Zwiers, PJ | 1 |
Moorlag, HE | 1 |
Zijlstra, JG | 1 |
Molema, G | 1 |
van Meurs, M | 1 |
Zuckermann, AM | 1 |
La Ragione, RM | 1 |
Baines, DL | 1 |
Williams, RS | 1 |
Chang, Z | 1 |
Wei, H | 1 |
Bonthrone, T | 1 |
Bonham, T | 1 |
de Vries, HE | 1 |
Piascik, P | 1 |
Georgoff, P | 1 |
Nikolian, V | 1 |
Allyn-Feuer, A | 1 |
Pauls, B | 1 |
Higgins, R | 1 |
Athey, BD | 1 |
Alam, HE | 1 |
Sailhamer, EA | 5 |
Yuan, Z | 1 |
Shults, C | 3 |
Velmahos, GC | 7 |
deMoya, M | 6 |
Shuja, F | 4 |
Butt, MU | 4 |
Gonzales, ER | 1 |
Chen, H | 2 |
Munuve, RM | 1 |
Mehrani, T | 1 |
Nadel, A | 1 |
Koustova, E | 2 |
Zacharias, N | 1 |
Fukudome, EY | 6 |
King, DR | 1 |
Dillon, ST | 1 |
Kheirbek, T | 2 |
Velmahos, G | 3 |
Libermann, TA | 1 |
Kochanek, AR | 3 |
Smith, EJ | 3 |
Kim, K | 3 |
Hamwi, K | 1 |
Hamwi, KB | 1 |
Fikry, K | 1 |
Bramos, A | 1 |
King, D | 1 |
Cotton, BA | 1 |
Hu, S | 1 |
Hou, JY | 1 |
Li, L | 1 |
Yang, MX | 1 |
Sheng, ZY | 1 |
Causey, MW | 1 |
Salgar, S | 1 |
Singh, N | 1 |
Martin, M | 1 |
Stallings, JD | 1 |
Imam, A | 1 |
Hwabejire, J | 1 |
Mejaddam, AY | 1 |
Smith, WM | 1 |
Lin, T | 1 |
Rhee, P | 1 |
Kirkpatrick, J | 1 |
Tabbara, M | 1 |
Fernandez-Fernandez, FJ | 1 |
Garcia-Rego, J | 1 |
Garcia-Jimenez, A | 1 |
Sesma, P | 1 |
4 reviews available for valproic acid and Hemorrhagic Shock
Article | Year |
---|---|
Life on the battlefield: Valproic acid for combat applications.
Topics: Animals; Armed Conflicts; Brain Injuries, Traumatic; Gene Expression; Histone Deacetylase Inhibitors | 2020 |
Different resuscitation strategies and novel pharmacologic treatment with valproic acid in traumatic brain injury.
Topics: Acetylation; Brain Injuries, Traumatic; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Humans; | 2018 |
Coagulation changes following traumatic brain injury and shock.
Topics: Animals; Blood Coagulation; Brain Injuries; Disease Models, Animal; Humans; Platelet Activation; Sho | 2014 |
Alternative fluids for prehospital resuscitation: "pharmacological" resuscitation fluids.
Topics: Adjuvants, Immunologic; Animals; Dehydroepiandrosterone; Emergency Medical Services; Enzyme Inhibito | 2011 |
1 trial available for valproic acid and Hemorrhagic Shock
Article | Year |
---|---|
Prolonging the therapeutic window for valproic acid treatment in a swine model of traumatic brain injury and hemorrhagic shock.
Topics: Animals; Brain Injuries, Traumatic; Disease Models, Animal; Resuscitation; Saline Solution; Shock, H | 2023 |
44 other studies available for valproic acid and Hemorrhagic Shock
Article | Year |
---|---|
Valproic acid during hypotensive resuscitation in pigs with trauma and hemorrhagic shock does not improve survival.
Topics: Animals; Blood Coagulation; Disease Models, Animal; Hemorrhage; Resuscitation; Shock, Hemorrhagic; S | 2022 |
VALPROIC ACID INHIBITS CLASSICAL MONOCYTE-DERIVED TISSUE FACTOR AND ALLEVIATES HEMORRHAGIC SHOCK-INDUCED ACUTE LUNG INJURY IN RATS.
Topics: Acute Lung Injury; Animals; Cytokines; Lung; Monocytes; Rats; Rats, Wistar; Shock, Hemorrhagic; Thro | 2023 |
VALPROIC ACID INHIBITS CLASSICAL MONOCYTE-DERIVED TISSUE FACTOR AND ALLEVIATES HEMORRHAGIC SHOCK-INDUCED ACUTE LUNG INJURY IN RATS.
Topics: Acute Lung Injury; Animals; Cytokines; Lung; Monocytes; Rats; Rats, Wistar; Shock, Hemorrhagic; Thro | 2023 |
VALPROIC ACID INHIBITS CLASSICAL MONOCYTE-DERIVED TISSUE FACTOR AND ALLEVIATES HEMORRHAGIC SHOCK-INDUCED ACUTE LUNG INJURY IN RATS.
Topics: Acute Lung Injury; Animals; Cytokines; Lung; Monocytes; Rats; Rats, Wistar; Shock, Hemorrhagic; Thro | 2023 |
VALPROIC ACID INHIBITS CLASSICAL MONOCYTE-DERIVED TISSUE FACTOR AND ALLEVIATES HEMORRHAGIC SHOCK-INDUCED ACUTE LUNG INJURY IN RATS.
Topics: Acute Lung Injury; Animals; Cytokines; Lung; Monocytes; Rats; Rats, Wistar; Shock, Hemorrhagic; Thro | 2023 |
Dose optimization of valproic acid in a lethal model of traumatic brain injury, hemorrhage, and multiple trauma in swine.
Topics: Animals; Brain Injuries, Traumatic; Disease Models, Animal; Dose-Response Relationship, Drug; Erythr | 2019 |
Valproic acid decreases resuscitation requirements after hemorrhage in a prolonged damage-control resuscitation model.
Topics: Animals; Blood Pressure; Disease Models, Animal; Female; Resuscitation; Shock, Hemorrhagic; Swine; V | 2020 |
Valproic acid treatment rescues injured tissues after traumatic brain injury.
Topics: Animals; Biomarkers; Brain; Brain Injuries, Traumatic; Disease Models, Animal; Female; Glial Fibrill | 2020 |
Modulation of Brain Transcriptome by Combined Histone Deacetylase Inhibition and Plasma Treatment Following Traumatic Brain Injury and Hemorrhagic Shock.
Topics: Animals; Blood Component Transfusion; Brain Injuries, Traumatic; Disease Models, Animal; Enzyme Inhi | 2021 |
Pharmacologic modulation of brain metabolism by valproic acid can induce a neuroprotective environment.
Topics: Animals; Brain Injuries, Traumatic; Disease Models, Animal; Female; Histone Deacetylase Inhibitors; | 2021 |
Administration of valproic acid in clinically approved dose improves neurologic recovery and decreases brain lesion size in swine subjected to hemorrhagic shock and traumatic brain injury.
Topics: Animals; Brain; Brain Injuries, Traumatic; Disease Models, Animal; Dose-Response Relationship, Drug; | 2021 |
Lung Protective Effects of Low-Volume Resuscitation and Pharmacologic Treatment of Swine Subjected to Polytrauma and Hemorrhagic Shock.
Topics: Animals; Caveolin 1; Cells, Cultured; Female; Human Umbilical Vein Endothelial Cells; Humans; Lung I | 2017 |
Valproic acid decreases brain lesion size and improves neurologic recovery in swine subjected to traumatic brain injury, hemorrhagic shock, and polytrauma.
Topics: Animals; Brain; Brain Injuries, Traumatic; Cognition; Disease Models, Animal; Enzyme Inhibitors; Fem | 2017 |
Improvement of Blood-Brain Barrier Integrity in Traumatic Brain Injury and Hemorrhagic Shock Following Treatment With Valproic Acid and Fresh Frozen Plasma.
Topics: Animals; Blood-Brain Barrier; Brain Injuries, Traumatic; Disease Models, Animal; Endothelium, Vascul | 2018 |
Valproic acid induces prosurvival transcriptomic changes in swine subjected to traumatic injury and hemorrhagic shock.
Topics: Animals; Disease Models, Animal; Female; GABA Agents; Multiple Trauma; Polymerase Chain Reaction; Ra | 2018 |
Histone deacetylase inhibitors: Isoform selectivity improves survival in a hemorrhagic shock model.
Topics: Animals; Apoptosis; Disease Models, Animal; Histone Deacetylase Inhibitors; Male; Myocardium; Phosph | 2018 |
Rapid valproic acid-induced modulation of the traumatic proteome in a porcine model of traumatic brain injury and hemorrhagic shock.
Topics: Animals; Brain Injuries, Traumatic; Disease Models, Animal; Female; Histone Deacetylase Inhibitors; | 2018 |
Valproic Acid and Neural Apoptosis, Inflammation, and Degeneration 30 Days after Traumatic Brain Injury, Hemorrhagic Shock, and Polytrauma in a Swine Model.
Topics: Animals; Apoptosis; Brain Injuries, Traumatic; Disease Models, Animal; Female; Histone Deacetylase I | 2019 |
Valproic acid improves survival and decreases resuscitation requirements in a swine model of prolonged damage control resuscitation.
Topics: Animals; Blood Pressure; Disease Models, Animal; Female; Heart Rate; Hemodynamics; Resuscitation; Sh | 2019 |
Pharmacologic modulation of cerebral metabolic derangement and excitotoxicity in a porcine model of traumatic brain injury and hemorrhagic shock.
Topics: Adenosine Triphosphate; Animals; Blood Glucose; Brain; Brain Injuries; Calcium; Cerebrovascular Circ | 2013 |
Synergistic effects of fresh frozen plasma and valproic acid treatment in a combined model of traumatic brain injury and hemorrhagic shock.
Topics: Animals; Brain; Brain Injuries; Female; Hemodynamics; Plasma; Resuscitation; Shock, Hemorrhagic; Swi | 2013 |
Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study.
Topics: Acetylation; Animals; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3; Glycogen Synthas | 2014 |
Creating a prosurvival phenotype through a histone deacetylase inhibitor in a lethal two-hit model.
Topics: Acute Lung Injury; Animals; Ascitic Fluid; Histone Deacetylase Inhibitors; Interleukin-6; Male; Pero | 2014 |
Treatment with a histone deacetylase inhibitor, valproic acid, is associated with increased platelet activation in a large animal model of traumatic brain injury and hemorrhagic shock.
Topics: Animals; Brain Injuries; CD40 Ligand; Disease Models, Animal; Female; Histone Deacetylase Inhibitors | 2014 |
Effect of pharmacologic resuscitation on the brain gene expression profiles in a swine model of traumatic brain injury and hemorrhage.
Topics: Animals; Brain Chemistry; Brain Injuries; Disease Models, Animal; Female; Histone Deacetylase Inhibi | 2014 |
Hypothermia and valproic acid activate prosurvival pathways after hemorrhage.
Topics: Acetylation; Animals; Arterial Pressure; Histone Deacetylase Inhibitors; Histones; Hypothermia, Indu | 2015 |
Histone Deacetylase Inhibition and IκB Kinase/Nuclear Factor-κB Blockade Ameliorate Microvascular Proinflammatory Responses Associated With Hemorrhagic Shock/Resuscitation in Mice.
Topics: Animals; Disease Models, Animal; Endothelial Cells; Histone Deacetylase Inhibitors; Histone Deacetyl | 2015 |
Valproic acid protects against haemorrhagic shock-induced signalling changes via PPARγ activation in an in vitro model.
Topics: Apoptosis; Cell Line, Tumor; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hy | 2015 |
Addition of low-dose valproic acid to saline resuscitation provides neuroprotection and improves long-term outcomes in a large animal model of combined traumatic brain injury and hemorrhagic shock.
Topics: Animals; Blotting, Western; Brain Injuries; Cognition; Disease Models, Animal; Female; Hydroxyethyl | 2015 |
Resuscitation with Valproic Acid Alters Inflammatory Genes in a Porcine Model of Combined Traumatic Brain Injury and Hemorrhagic Shock.
Topics: Animals; Brain; Brain Injuries, Traumatic; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Fem | 2016 |
Valproic acid modulates platelet and coagulation function ex vivo.
Topics: Animals; Blood Coagulation; Blood Platelets; Brain Injuries; Platelet Aggregation; Shock, Hemorrhagi | 2017 |
Network Reconstruction Reveals that Valproic Acid Activates Neurogenic Transcriptional Programs in Adult Brain Following Traumatic Injury.
Topics: Adult; Animals; Anticonvulsants; Brain; Brain Injuries, Traumatic; Cell Line, Tumor; Gene Expression | 2017 |
Cell protective mechanism of valproic acid in lethal hemorrhagic shock.
Topics: Acetylation; Animals; beta Catenin; Cell Nucleus; Cells, Cultured; Cerebral Cortex; Cytosol; Gene Ex | 2008 |
Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock.
Topics: Acetylation; Animals; Disease Models, Animal; Enzyme Inhibitors; Histone Deacetylase Inhibitors; His | 2008 |
Surviving blood loss without blood transfusion in a swine poly-trauma model.
Topics: Animals; beta Catenin; Blood Pressure; Blood Transfusion; Female; Femoral Fractures; Glycogen Syntha | 2009 |
Pharmacologic resuscitation: cell protective mechanisms of histone deacetylase inhibition in lethal hemorrhagic shock.
Topics: Animals; Apoptosis; Caspase 3; Cell Survival; Disease Models, Animal; Enzyme Inhibitors; Histone Dea | 2009 |
Identification of a novel potential biomarker in a model of hemorrhagic shock and valproic acid treatment.
Topics: Animals; Anticonvulsants; Biomarkers; Blotting, Western; Claudin-3; Intestinal Mucosa; Male; Membran | 2010 |
Pharmacologic resuscitation promotes survival and attenuates hemorrhage-induced activation of extracellular signal-regulated kinase 1/2.
Topics: Animals; Extracellular Signal-Regulated MAP Kinases; Histone Acetyltransferases; Histone Deacetylase | 2010 |
Hemostatic and pharmacologic resuscitation: results of a long-term survival study in a swine polytrauma model.
Topics: Analysis of Variance; Animals; Blood Proteins; Blood Transfusion; Disease Models, Animal; Hemostasis | 2011 |
Histone deacetylase inhibitor treatment attenuates MAP kinase pathway activation and pulmonary inflammation following hemorrhagic shock in a rodent model.
Topics: Animals; Apoptosis; Disease Models, Animal; Histone Deacetylase Inhibitors; Lung; Male; Mitogen-Acti | 2012 |
[The effects of administration of valproic acid on organ function and outcome in a canine lethal hemorrhagic shock model].
Topics: Animals; Blood Pressure; Blood Volume; Disease Models, Animal; Dogs; Male; Prognosis; Shock, Hemorrh | 2011 |
Valproic acid reversed pathologic endothelial cell gene expression profile associated with ischemia-reperfusion injury in a swine hemorrhagic shock model.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Gene Exp | 2012 |
Pharmacologic resuscitation decreases circulating cytokine-induced neutrophil chemoattractant-1 levels and attenuates hemorrhage-induced acute lung injury.
Topics: Acute Lung Injury; Animals; Chemokine CXCL1; Histone Deacetylase Inhibitors; Lung; Peroxidase; Rats; | 2012 |
Pharmacologic resuscitation for hemorrhagic shock combined with traumatic brain injury.
Topics: Animals; Brain Injuries; Disease Models, Animal; Drug Therapy, Combination; Female; Hemodynamics; Hy | 2012 |
Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver.
Topics: Acetylation; Animals; Enzyme Inhibitors; Gene Expression; Histone Acetyltransferases; Histone Deacet | 2007 |
Surviving blood loss without fluid resuscitation.
Topics: Analysis of Variance; Animals; Chi-Square Distribution; Histone Deacetylase Inhibitors; Hydroxamic A | 2008 |
[Hemorrhagic shock and fulminant hepatic failure associated with valproate].
Topics: Anticonvulsants; Child; Hepatic Encephalopathy; Humans; Liver; Male; Shock, Hemorrhagic; Status Epil | 1995 |